Immatics N.V.(IMTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IMTX Immatics N.V.

盘后交易 11-26 16:36:48 EST

7.80

+0.21

+2.77%

盘后7.80

+0.000.00%

16:00 EST

最高7.93	最低7.48	成交量71.04万
今开7.68	昨收7.59	日振幅5.99%
总市值9.31亿	流通市值5.74亿	总股本1.19亿
成交额546.24万	换手率0.97%	流通股本7,361万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"IMTX","market":"US","secType":"STK","nameCN":"Immatics N.V.","latestPrice":7.8,"timestamp":1732654800000,"preClose":7.59,"halted":0,"volume":710429,"hourTrading":{"tag":"盘后","latestPrice":7.8,"preClose":7.8,"latestTime":"16:00 EST","volume":12719,"amount":99208.2,"timestamp":1732654806620},"delay":0,"floatShares":73612200,"shares":119355906,"eps":-0.678759,"marketStatus":"盘后交易","marketStatusCode":4,"change":0.21,"latestTime":"11-26 16:36:48 EST","open":7.68,"high":7.93,"low":7.475,"amount":5462421.587545,"amplitude":0.059947,"askPrice":7.82,"askSize":100,"bidPrice":7.75,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.678759,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1732669200000},"adr":0,"adjPreClose":7.59,"preHourTrading":{"tag":"盘前","latestPrice":7.75,"preClose":7.59,"latestTime":"09:22 EST","volume":2055,"amount":16154.730448499999,"timestamp":1732630936223},"postHourTrading":{"tag":"盘后","latestPrice":7.8,"preClose":7.8,"latestTime":"16:00 EST","volume":12719,"amount":99208.2,"timestamp":1732654806620},"volumeRatio":0.996631,"impliedVol":0.1668,"impliedVolPercentile":0.087},"requestUrl":"/m/hq/s/IMTX/wiki","defaultTab":"wiki","newsList":[{"id":"2485620098","title":"Immatics N.V.2024财年第三财季实现净利润-9.41百万美元，同比增加67.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485620098","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485620098?lang=zh_cn&edition=full","pubTime":"2024-11-24 00:00","pubTimestamp":1732377628,"startTime":"0","endTime":"0","summary":"11月24日，Immatics N.V.公布财报，公告显示公司2024财年第三财季净利润为-9.41百万美元，同比增加67.35%；其中营业收入为55.54百万美元，同比增加761.09%，每股基本收益为-0.09美元。从资产负债表来看，Immatics N.V.总负债2.17亿美元，其中短期债务19.63百万美元，资产负债比为2.97，流动比率为3.98。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241124000052a2504586&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241124000052a2504586&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMTX"],"gpt_icon":0},{"id":"2483530595","title":"Immatics N.V.盘中异动 股价大跌5.04%报8.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483530595","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483530595?lang=zh_cn&edition=full","pubTime":"2024-11-15 23:47","pubTimestamp":1731685663,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日23时47分，Immatics N.V.股票出现波动，股价大幅跳水5.04%。截至发稿，该股报8.10美元/股，成交量17.9562万股，换手率0.15%，振幅6.57%。Immatics N.V.股票所在的生物技术行业中，整体跌幅为3.35%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。该公司通过与第三方制药和生物技术公司的战略合作协议获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115234744971a6e72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115234744971a6e72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMTX"],"gpt_icon":0},{"id":"2483039219","title":"Immatics N.V.盘中异动 股价大跌5.09%报8.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483039219","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483039219?lang=zh_cn&edition=full","pubTime":"2024-11-13 01:10","pubTimestamp":1731431413,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日01时10分，Immatics N.V.股票出现异动，股价大幅下挫5.09%。截至发稿，该股报8.58美元/股，成交量32.0911万股，换手率0.27%，振幅4.09%。Immatics N.V.股票所在的生物技术行业中，整体跌幅为0.70%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。该公司通过与第三方制药和生物技术公司的战略合作协议获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111301101398e4224a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111301101398e4224a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMTX"],"gpt_icon":0},{"id":"2474746561","title":"Immatics N.V.盘中异动 快速跳水5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474746561","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474746561?lang=zh_cn&edition=full","pubTime":"2024-10-10 21:34","pubTimestamp":1728567242,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日21时34分，Immatics N.V.股票出现异动，股价快速下挫5.15%。截至发稿，该股报10.50美元/股，成交量16.588万股，换手率0.16%，振幅6.68%。Immatics N.V.股票所在的生物技术行业中，整体涨幅为0.00%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。该公司通过与第三方制药和生物技术公司的战略合作协议获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241010213402959da392&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241010213402959da392&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMTX","BK4139"],"gpt_icon":0},{"id":"2473899115","title":"Immatics N.V.盘中异动 急速拉升5.17%报10.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473899115","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473899115?lang=zh_cn&edition=full","pubTime":"2024-10-05 03:26","pubTimestamp":1728069999,"startTime":"0","endTime":"0","summary":"北京时间2024年10月05日03时26分，Immatics N.V.股票出现异动，股价快速上涨5.17%。截至发稿，该股报10.88美元/股，成交量19.129万股，换手率0.19%，振幅3.91%。Immatics N.V.股票所在的生物技术行业中，整体跌幅为0.12%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。该公司通过与第三方制药和生物技术公司的战略合作协议获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241005032639ab67c4a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241005032639ab67c4a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMTX"],"gpt_icon":0},{"id":"2472505943","title":"Immatics N.V.盘中异动 快速跳水5.00%报10.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472505943","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472505943?lang=zh_cn&edition=full","pubTime":"2024-10-03 03:20","pubTimestamp":1727896839,"startTime":"0","endTime":"0","summary":"北京时间2024年10月03日03时20分，Immatics N.V.股票出现波动，股价急速跳水5.00%。截至发稿，该股报10.65美元/股，成交量20.2324万股，换手率0.20%，振幅5.31%。Immatics N.V.股票所在的生物技术行业中，整体跌幅为1.12%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。该公司通过与第三方制药和生物技术公司的战略合作协议获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100303203998e3a42b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100303203998e3a42b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMTX","BK4139"],"gpt_icon":0},{"id":"2459152417","title":"Immatics N.V.2024财年第二财季实现净利润-19.40百万美元，同比增加27.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459152417","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459152417?lang=zh_cn&edition=full","pubTime":"2024-08-14 07:08","pubTimestamp":1723590511,"startTime":"0","endTime":"0","summary":"8月14日，Immatics N.V.公布财报，公告显示公司2024财年第二财季净利润为-19.40百万美元，同比增加27.56%；其中营业收入为20.19百万美元，同比减少17.02%，每股基本收益为-0.18美元。从资产负债表来看，Immatics N.V.总负债2.56亿美元，其中短期债务23.34百万美元，资产负债比为2.63，流动比率为3.75。机构评级：截至2024年8月14日，当前有5家机构对Immatics N.V.目标价做出预测，其中目标均价为18.10美元，其中最低目标价为14.16美元，最高目标价为20.22美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408140708379f289132&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408140708379f289132&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMTX"],"gpt_icon":0},{"id":"2453064734","title":"Immatics N.V.盘中异动 下午盘急速上涨5.10%报12.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453064734","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453064734?lang=zh_cn&edition=full","pubTime":"2024-07-24 03:27","pubTimestamp":1721762863,"startTime":"0","endTime":"0","summary":"北京时间2024年07月24日03时27分，Immatics N.V.股票出现异动，股价快速上涨5.10%。截至发稿，该股报12.98美元/股，成交量52.5168万股，换手率0.51%，振幅6.68%。Immatics N.V.股票所在的生物技术行业中，整体跌幅为0.09%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724032744aefb0a09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724032744aefb0a09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMTX"],"gpt_icon":0},{"id":"2450545534","title":"Immatics N.V.盘中异动 快速上涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450545534","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450545534?lang=zh_cn&edition=full","pubTime":"2024-07-12 22:29","pubTimestamp":1720794549,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日22时29分，Immatics N.V.股票出现波动，股价快速上涨5.07%。截至发稿，该股报12.86美元/股，成交量7.3815万股，换手率0.07%，振幅5.47%。Immatics N.V.股票所在的生物技术行业中，整体涨幅为1.45%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。该公司通过与第三方制药和生物技术公司的战略合作协议获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712222909aef97c9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712222909aef97c9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMTX","BK4139"],"gpt_icon":0},{"id":"2442435153","title":"Immatics N.V.盘中异动 股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442435153","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2442435153?lang=zh_cn&edition=full","pubTime":"2024-06-12 02:42","pubTimestamp":1718131360,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日02时42分，Immatics N.V.股票出现波动，股价急速上涨5.05%。截至发稿，该股报13.53美元/股，成交量33.055万股，换手率0.32%，振幅6.99%。Immatics N.V.股票所在的生物技术行业中，整体跌幅为0.28%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。该公司通过与第三方制药和生物技术公司的战略合作协议获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612024241968136e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612024241968136e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMTX"],"gpt_icon":0},{"id":"2441820802","title":"Immatics N.V.盘中异动 股价大涨5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2441820802","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441820802?lang=zh_cn&edition=full","pubTime":"2024-06-05 23:45","pubTimestamp":1717602350,"startTime":"0","endTime":"0","summary":"北京时间2024年06月05日23时45分，Immatics N.V.股票出现异动，股价快速上涨5.39%。截至发稿，该股报13.09美元/股，成交量18.8343万股，换手率0.18%，振幅5.55%。Immatics N.V.股票所在的生物技术行业中，整体涨幅为1.28%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。该公司通过与第三方制药和生物技术公司的战略合作协议获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605234550aef39270&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605234550aef39270&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMTX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.immatics.com","stockEarnings":[{"period":"1week","weight":-0.0294},{"period":"1month","weight":-0.1803},{"period":"3month","weight":-0.3056},{"period":"6month","weight":-0.3429},{"period":"1year","weight":-0.0996},{"period":"ytd","weight":-0.2792}],"compareEarnings":[{"period":"1week","weight":0.0159},{"period":"1month","weight":0.0319},{"period":"3month","weight":0.0641},{"period":"6month","weight":0.1358},{"period":"1year","weight":0.3124},{"period":"ytd","weight":0.2571}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Immatics N.V.是一家荷兰私人有限责任公司，于2020年3月10日成立。该公司是一家专注于开发基于T细胞受体的免疫疗法的生物制药公司。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.063537},{"month":2,"riseRate":0.75,"avgChangeRate":-0.011615},{"month":3,"riseRate":0.25,"avgChangeRate":-0.076889},{"month":4,"riseRate":0.5,"avgChangeRate":0.010902},{"month":5,"riseRate":0.5,"avgChangeRate":0.086457},{"month":6,"riseRate":1,"avgChangeRate":0.113651},{"month":7,"riseRate":1,"avgChangeRate":0.09814},{"month":8,"riseRate":0.4,"avgChangeRate":-0.003927},{"month":9,"riseRate":0.4,"avgChangeRate":-0.019872},{"month":10,"riseRate":0.4,"avgChangeRate":-0.06624},{"month":11,"riseRate":0.2,"avgChangeRate":-0.061078},{"month":12,"riseRate":0.75,"avgChangeRate":0.065405}],"exchange":"NASDAQ","name":"Immatics N.V.","nameEN":"Immatics N.V."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Immatics N.V.(IMTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Immatics N.V.(IMTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Immatics N.V.,IMTX,Immatics N.V.股票,Immatics N.V.股票老虎,Immatics N.V.股票老虎国际,Immatics N.V.行情,Immatics N.V.股票行情,Immatics N.V.股价,Immatics N.V.股市,Immatics N.V.股票价格,Immatics N.V.股票交易,Immatics N.V.股票购买,Immatics N.V.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Immatics N.V.(IMTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Immatics N.V.(IMTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}